Sequoia Sciences is Biotechnology in United States that focus on chronic infections business. Founded in 1999. They cover business area such as developer, new medicine, vaccine, acute bacterial infection, cancer, advanced purification and characterization technology, high-throughput screening, compound, quantity, traditional extract screening, doctor, urinary tract infection, chronic infection, bacterial biofilm.
1999
( 25 years old in 2024 )
Chronic Infections
-
1912 Innerbelt Business Center Drive
Saint Louis, MO 63114
United States
Private
developernew medicinevaccineacute bacterial infectioncanceradvanced purification and characterization technologyhigh-throughput screeningcompoundquantitytraditional extract screeningdoctorurinary tract infectionchronic infectionbacterial biofilm
* We use standard office opening hours in near Sequoia Sciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sequoia Sciences is Biotechnology business from United States that founded in 1999 (25 years old in 2024), Sequoia Sciences business is focusing on Chronic Infections.
Sequoia Sciences headquarter office and corporate office address is located in 1912 Innerbelt Business Center Drive Saint Louis, MO 63114 United States.
Sequoia Sciences was founded in United States.
In 2024, Sequoia Sciences is currently focus on chronic infections sector.
Above is snippet of Google Trends for "chronic infections" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sequoia Sciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
